Affordable Access

deepdyve-link
Publisher Website

Momordica charantia for type 2 diabetes mellitus.

Authors
  • Ooi, Cheow Peng
  • Yassin, Zaitun
  • Hamid, Tengku-Aizan
Type
Published Article
Journal
The Cochrane database of systematic reviews
Publication Date
Jan 01, 2010
Issue
2
Identifiers
DOI: 10.1002/14651858.CD007845.pub2
PMID: 20166099
Source
Medline
License
Unknown

Abstract

There is insufficient evidence to recommend momordica charantia for type 2 diabetes mellitus. Further studies are therefore required to address the issues of standardization and the quality control of preparations. For medical nutritional therapy, further observational trials evaluating the effects of momordica charantia are needed before RCTs are established to guide any recommendations in clinical practice.

Report this publication

Statistics

Seen <100 times